Literature DB >> 30851827

Minimally Invasive Approaches to Pancreatic Cancer.

Joseph R Broucek1, Dominic Sanford2, John A Stauffer3, Horacio J Asbun4.   

Abstract

In pancreatic cancer, resection combined with neoadjuvant and/or adjuvant therapy remains the only chance for cure and/or prolonged survival. A minimally invasive approach to pancreatic cancer has gained increased acceptance and popularity. The aim of minimally invasive surgery of the pancreas includes limiting trauma, decreasing length of hospitalization, lessening cost, decreasing blood loss, and allowing for a more meticulous oncologic dissection. New advances and routine use in practice have helped progress the field making the minimally invasive approach more feasible. In this article, the minimally invasive surgical approaches to proximal, central, and distal pancreatic cancer are described and literature reviewed.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Laparoscopic whipple; Minimally invasive pancreaticoduodenectomy; Minimally invasive surgery; Minimally invasive whipple; Pancreas

Mesh:

Year:  2019        PMID: 30851827     DOI: 10.1016/j.soc.2018.11.006

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  2 in total

Review 1.  International expert consensus on laparoscopic pancreaticoduodenectomy.

Authors:  Renyi Qin; Michael L Kendrick; Christopher L Wolfgang; Barish H Edil; Chinnusamy Palanivelu; Rowan W Parks; Yinmo Yang; Jin He; Taiping Zhang; Yiping Mou; Xianjun Yu; Bing Peng; Palanisamy Senthilnathan; Ho-Seong Han; Jae Hoon Lee; Michiaki Unno; Steven W M Olde Damink; Virinder Kumar Bansal; Pierce Chow; Tan To Cheung; Nim Choi; Yu-Wen Tien; Chengfeng Wang; Manson Fok; Xiujun Cai; Shengquan Zou; Shuyou Peng; Yupei Zhao
Journal:  Hepatobiliary Surg Nutr       Date:  2020-08       Impact factor: 7.293

2.  Laparoscopic versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a propensity score matching analysis.

Authors:  Wentao Zhou; Weiwei Jin; Dansong Wang; Chao Lu; Xuefeng Xu; Renchao Zhang; Tiantao Kuang; Yucheng Zhou; Wenchuan Wu; Dayong Jin; Yiping Mou; Wenhui Lou
Journal:  Cancer Commun (Lond)       Date:  2019-10-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.